Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004800

Director sold 15,664 shares at $7.94 ($124,372)

  • Director acquired 15,394 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

GRIFFIN MICHELLE RENEE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-04 Grant or award : show line 1 in the form 10b5-1 +15,394 67,349 D
2025-03-06 Sale : show line 2 in the form 10b5-1 −15,664 $7.94 $124,372 51,685 D
Open-market sales · 15,664 sh · avg $7.94 · $124,372

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-04 Grant or award : show line 3 in the form 10b5-1 Stock Option (right to buy) +23,726 23,726 D
Loading xslF345X05/form4.xml…